HomeTLX • ASX
add
Telix Pharmaceuticals Ltd
Nakaraang pagsara
$23.99
Sakop ng araw
$23.67 - $24.20
Sakop ng taon
$10.34 - $25.80
Market cap
8.04B AUD
Average na Volume
982.66K
P/E ratio
160.45
Dividend yield
-
Primary exchange
ASX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 188.96M | 58.05% |
Gastos sa pagpapatakbo | 92.39M | 161.35% |
Net na kita | 11.68M | 300.41% |
Net profit margin | 6.18 | 226.90% |
Kita sa bawat share | — | — |
EBITDA | 20.37M | -47.25% |
Aktuwal na % ng binabayarang buwis | -27.75% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 118.84M | -9.79% |
Kabuuang asset | 745.96M | 140.37% |
Kabuuang sagutin | 341.98M | 45.97% |
Kabuuang equity | 403.97M | — |
Natitirang share | 334.23M | — |
Presyo para makapag-book | 19.83 | — |
Return on assets | 7.63% | — |
Return on capital | 14.32% | — |
Cash Flow
Net change in cash
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 11.68M | 300.41% |
Cash mula sa mga operasyon | 33.61M | 210.88% |
Cash mula sa pag-invest | -36.93M | -2,854.32% |
Cash mula sa financing | 3.62M | 29.26% |
Net change in cash | -3.87M | -137.31% |
Malayang cash flow | 104.20M | — |
Tungkol
Itinatag
2015
Website
Mga Empleyado
423
